ClinicalTrialsFinder
RecruitingNot ApplicableNCT06280885

A Flexible Individualized ExeRcise Programme for Cancer Patients During ChEmotherapy

Sponsor

University of Dublin, Trinity College

Enrollment

50 participants

Start Date

Jan 1, 2025

Study Type

INTERVENTIONAL

Conditions

Cancer

Summary

The primary aim of this study is to measure the feasibility of delivering a co-designed exercise programme for patients with cancer receiving chemotherapy treatment.

Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Aged >18.
  • Histological confirmed diagnosis of stage I to IIIc breast, ovarian or colorectal cancer.
  • Scheduled to receive chemotherapy ± immunotherapy with curative intent.
  • Medical clearance from oncologist to partake in regular exercise in accordance with American College of Sports Medicine (ACSM) preparticipation screening algorithm.
  • Ability to provide written informed consent.

Exclusion Criteria3

  • Advanced/metastatic disease.
  • Scheduled to receive concurrent chemoradiotherapy.
  • Scheduled to receive high-dose chemotherapy during hospital admission.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALExercise

Participants will be randomised to either the FIERCE exercise programme involving supervised exercise prescription

BEHAVIORALHealth Behaviour Change (Pedometer)

Participants in both arms will be provided with a pedometer as a health behaviour change intervention

Locations(1)

St James's Hospital

Dublin, Ireland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06280885

Related Trials

The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials

NCT067566071 location

Patient-Centered Assessment of Symptoms and Outcomes

NCT039526241 location

A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

NCT055881411 location

Tumor Related Epilepsy

NCT026393251 location

Improving Engagement in HIV and Cancer Care in Zimbabwe

NCT069343691 location